Skip to content
value.today

Allakos Inc.

ALLKUnlisted company
$239 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2020 ending year
value.today research
Net income
$-153 M
value.today research
Employees
192
As on 2021
value.today research

Allakos Inc. in brief

Allakos Inc. is an unlisted company in the Biotechnology industry, based in California, USA. It was founded in 2012. In the year to Dec 2020 it had sales of $0 M and a net loss of $153 M. It employs about 192 people.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Allakos Inc.

ALLAKOS is Biotechnology sector company with headquarters is in USA.They are developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases

Allakos Inc. timeline

2 events, 2012–2018
  1. 2012
  2. 🏁
    · approximate
    Founded
  3. 2018
  4. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Allakos Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Allakos Inc.

Acquisitions and changes
No longer listed: ticker ALLK is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$2.0 B$4.0 B$6.0 B$7.9 B20202021202220232024

World rank over time

▼ down 14,685 places since 2020
2020-01-01: #2304#2,30420202021-01-01: #2162#2,16220212022-01-07: #13924#13,92420222022-12-25: #10705#10,70520222023-07-30: #13455#13,45520232024-01-05: #16989#16,9892024

Rank in USA: #771 (Jan 2020) · #752 (Jan 2021) · #3,021 (Jan 2022) · #2,353 (Dec 2022) · #2,796 (Jul 2023) · #3,118 (Jan 2024)

Annual results

Revenue
$0 M
Operating income
—
Net income
$-153 M

Dec-2020 ending year

Markets and events: Allakos Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2025-05-15
460,727
1 days to cover
Shares sold short, last 13 reportsAll stocks →

Trading halts

  • 2025-05-14 23:50 UTC, code D, resumed 04:00 UTC
  • 2025-04-02 11:55 UTC, code T3, resumed 12:30 UTC
  • 2025-01-27 11:55 UTC, code T3, resumed 12:30 UTC

Fails to deliver

  • : 147 shares at $0.33
  • : 31,674 shares at $0.33
  • : 5 shares at $0.32
  • : 337 shares at $0.32
  • : 1,280 shares at $0.32

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

H-1B hiring at Allakos Inc.#

1 labor condition applications certified in fiscal 2025 for 1 positions, at a median wage of $104 K a year.

Certified, FY2025
1
#1,886 among companies on value.today
Worker positions
1
Median wage offered
$104 K
a year, full-time
Applications filed
1
Allakos Inc.: most frequent H-1B job titles in fiscal 2025
Job titlePositionsMedian wage offered
Data AnalystData Scientists1$104 K

Where: San Jose, CA 1

Allakos Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202511$104 K1
FY202422$226 K2
FY202333$199 K3
FY202222$175 K2
FY202133$190 K3
FY202011$170 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Allakos Inc.

Layoffs at Allakos Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
120
2022–2024
Latest
59 people
2024-01-16
Allakos Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
202459···········59
2022·61··········61
Allakos Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
effective 59 peopleLayoffWARN noticeSan Carlos, CaliforniaNotice list
effective 61 peopleLayoffWARN noticeRedwood City, CaliforniaNotice list

Source: State WARN notices and SEC 8-K item 2.05

How Allakos Inc. compares in Biotechnology

  • Revenue$0 M · higher than 0% of 647

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Allakos Inc.🇺🇸$239 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Employees:
As on 2021
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Allakos Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Allakos Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Allakos Inc.? Suggest a correction